The FFAT motif is a targeting signal responsible for localizing a number of proteins to the cytosolic surface of the endoplasmic reticulum (ER) and to the nuclear membrane. FFAT motifs bind to the highly conserved protein VAP-33, which is tethered to the cytoplasmic face of the ER by a C-terminal transmembrane domain. We find that VAP proteins bind FFAT motifs through a highly conserved N-terminal Major Sperm Protein (MSP) homology domain with 1:1 stoichiometry. We have solved crystal structures of the rat VAP-A MSP homology domain alone and in complex with an FFAT motif. The co-crystal structure was used to design a VAP 
Introduction
The endoplasmic reticulum (ER) is a multi-functional organelle. After translocation across the ER membrane, secreted proteins fold, undergo post-translational modification and assemble into multi-protein complexes in the ER lumen (Baumann and Walz, 2001 ).
Additionally, the cytosolic surface of the ER membrane is a major site for lipid biosynthesis, and many peripheral membrane proteins are localized to the cytosolic surface of the ER membrane (Baumann and Walz, 2001 ). While the mechanism by which proteins are targeted for translocation into the ER lumen is well characterized, it is not well understood how proteins are targeted to the cytosolic surface of the ER. Recent work has identified a targeting signal (the FFAT motif) responsible for targeting cytosolic proteins to the surface of the ER (Loewen et al., 2003) and to the nuclear membrane (Brickner and Walter, 2004) . The FFAT motif has the consensus amino acid sequence EFFDAxE (Loewen et al., 2003) . This motif was identified because it is conserved in a large family of Oxysterol Binding Protein Related Proteins (ORPs) ( Figure 1A and Supplemental Figure 1A ) (Loewen et al., 2003) . ORPs are regulators of lipid metabolism that are targeted by their FFAT motifs to the cytosolic surface of the ER (Loewen et al., 2003) . In both yeast and mammals, proteins containing exposed FFAT motifs are targeted to ER membranes by interactions with VAP proteins (Loewen et al., 2003; Wyles et al., 2002) .
VAP proteins are type-IV transmembrane proteins composed of 3 conserved domains.
These include an N-terminal immunoglobulin-like beta sheet, a central coiled-coil domain, and a C-terminal transmembrane domain ( Figure 1A ). The N-terminal domain shares 22% sequence identity with the well characterized Major Sperm Protein (MSP) ( Figure 1A and Supplemental Figure 1B ) (Roberts and Stewart, 2000) . However, it is unclear whether VAP proteins share a common function. In metazoans, in addition to its role in recruiting FFAT motif-targeted proteins to ER membranes (Brickner and Walter, 2004; Kagiwada et al., 1998; Loewen and Levine, 2005; Loewen et al., 2003; Skehel et al., 2000; Soussan et al., 1999; Wyles et al., 2002; Wyles and Ridgway, 2004) , VAP has been proposed to function in vesicle trafficking (Amarilio et al., 2005; Foster et al., 2000; Skehel et al., 1995) , and in the organization of microtubule networks (Amarilio et al., 2005; Pennetta et al., 2002) . Scs2p, the yeast homologue of VAP, binds FFAT motifs, and yeast lacking Scs2p mislocalize FFAT-targeted proteins to the cytoplasm (Loewen et al., 2003) . In addition to its role in recruiting ORPs to the ER, Scs2p has also been implicated in transcriptional regulation of the INO1 gene that encodes an important phospholipid biosynthetic protein (Brickner and Walter, 2004; Kagiwada et al., 1998) . Strains lacking SCS2 are unable to activate the INO1 gene and cannot grow in the absence of inositol.
Opi1p, a transcriptional repressor of INO1 that possesses an FFAT motif ( Figure 1A ), is regulated by Scs2p on the nuclear membrane (Brickner and Walter, 2004; Loewen et al., 2003) .
Here we present the crystal structure for a VAP-FFAT motif interaction. We find that the specific molecular interactions between FFAT and VAP are highly conserved from yeast to mammals. Based on our structure of the VAP-FFAT complex we designed mutants of the yeast VAP homologue Scs2p that are defective for FFAT motif binding. These mutants were defective for activation of INO1, indicating that FFAT-mediated binding of Scs2p to Opi1p is essential for this activation event. Finally, overexpression of wild-type VAP or of VAP defective for FFAT binding alters ER morphology in distinct patterns, suggesting that VAP and FFAT-proteins play an important role in maintaining ER morphology.
Results and Discussion

VAP Interacts With Proteins Containing FFAT Motifs
To investigate VAP function, we analyzed the ability of VAP proteins to interact with putative binding partners that were suggested in previous reports (Pennetta et al., 2002; Skehel et al., 2000; Weir et al., 2001; Wyles et al., 2002) . We were able to reproduce the reported interaction between VAP homologues and proteins containing FFAT motifs (Loewen and Levine, 2005; Loewen et al., 2003) with purified proteins in vitro. However, we found no evidence for direct interactions of cytosolic portions of VAP with cytosolic portions of SNARE proteins or with tubulin or microtubules (data not shown). The stoichiometry of VAP-FFAT interaction was determined by size exclusion chromatography coupled to in-line multi-angle laser light scattering (SEC-MALLS); recombinant rat ORP1 (454-546) (which contains the ORP1 FFAT motif) interacts with rat VAP (1-125) in a 1:1 complex (Supplemental Figure 2) .
The interaction between VAP proteins and FFAT motifs was also confirmed by a native gelshift assay ( Figure 1B 
Crystal Structure of the rat VAP-A MSP homology domain
To find a stable fragment of VAP-A that would be suitable for crystallography, we performed limited trypsin digestion of the cytosolic portion of rat VAP-A (residues 1-219). We obtained a stable fragment consisting of VAP-A residues 1-123 as measured by MALDI mass spectrometry (data not shown). Secondary structure predictions (Rost and Liu, 2003) suggest that VAP-A residue 125 is the end of the beta strand that contains residue 123. We thus expressed, purified and crystallized VAP (1-125).
The crystal structure of selenomethionine-substituted rat VAP-A (1-125) was solved to 1.7 Å resolution using data from a multiwavelength anomalous dispersion (MAD) experiment (Table 1) (Hendrickson, 1991) . As expected from sequence homology, the fold of VAP-A (1-125) is the same as that of MSP. Both are seven-stranded immunoglobulin-like β-sandwiches with s-type topology and their C α backbones align with an r.m.s.d. of 2.0 Å over 109 residues (Bullock et al., 1996) . Although they share the same fold and 22% sequence identity, VAP (1-125) and MSP have distinct surface electrostatic properties (Figure 2 ) and behave differently in solution. While MSP forms a symmetric dimer ( Figures 2C and 2D ) with a K d of less than 50 nM (Haaf et al., 1996) , VAP (1-125) is monomeric in solution as measured by SEC-MALLS (Supplemental Figure 2) . VAP (1-125) crystallizes with one molecule in the asymetric unit, but forms a symmetric crystal contact across a crystallographic two-fold interface with a buried surface area of 440 Å 2 . This interface is centered on a highly conserved sequence that contains
Cys53. In approximately 50% of the crystal, Cys53 residues are disulfide bonded across this crystallographic interface, likely representing an artifact of crystallization. It is therefore noteworthy that VAP (1-125) is monomeric in solution and that at the high protein concentration required for crystallization, none of the crystal contacts correspond to the MSP dimer interface.
Indeed, critical residues in the MSP dimerization interface, such as Val18 and Tyr29, are not conserved in VAP (1-125) (Bullock et al., 1996) . These residues are instead replaced in VAP-A by polar residues Lys17 and Thr28 (Bullock et al., 1996) . We conclude that VAP (1-125) does not dimerize in the same way as MSP.
Crystal Structure of a VAP-FFAT complex
We next sought to determine the structural basis for the interaction between VAP proteins and FFAT motifs. We solved the structure of rat VAP-A (1-125) in complex with the rat ORP1 FFAT motif (residues 472-SEDEFYDALS-481) using diffraction data from a single wavelength anomalous dispersion (SAD) experiment and a 1.9 Å native data set (Table 2 ) (Hendrickson, 1991) . The structure of VAP (1-125) is subtly changed by FFAT binding. VAP C α backbones from our structures align with an r.m.s.d. of 1.3 Å over 113 residues. The FFAT motif binds across VAP beta strands F, E, C, and D1 ( Figure 3A ). FFAT binding causes small (0.1-0.5 Å) changes in the position of backbone atoms within these strands and substantial changes (2-4 Å) in the position of several side-chain atoms that accommodate FFAT binding.
We observe clear electron density for main and side chain atoms of ORP1 FFAT residues 476-481 and main chain atoms of residues 473-475 ( Figure 3B ). The FFAT residue Phe476 binds VAP in a hydrophobic pocket created by the aliphatic amino acid side chains of several residues ( Figure 3B ). It has extensive hydrophobic Van der Waals contacts with VAP-A residue Met89
and with aliphatic portions of side chains from VAP-A residues Lys45, Thr47, Lys87 and Lys118 ( Figure 3B ).
The FFAT motif binds VAP on a positive patch that is in a highly conserved region on the VAP protein surface ( Figures 3C and 3D) . Part of the FFAT binding site on the yeast VAP homologue Scs2p was recently identified by a mutagenic screen (Loewen and Levine, 2005 Figure 1A ). Asp478 forms symmetric hydrogen bonds between the two FFAT motifs within a 2:2 complex ( Figure 4C ). These symmetric hydrogen bonds may explain the high conservation of Asp478 in FFAT motifs (Supplemental Figure 1A ). As described above, the side-chain of FFAT residue Tyr477 is only weakly restrained by the VAP surface to which it is primarily bound. This residue is further restrained by hydrophobic Van der Waals contact with an aliphatic portion of the Asp478 side chain from the second FFAT motif within a 2:2 complex. Another argument for the relevance of the 2:2 complex is that it could form in the context of full-length VAP and full-length ORP1. The C-termini of the two VAP (1-125) domains project from the same face of a 2:2 complex ( Figure 4A ). The termini of the bound ORP1 peptide are oriented in a way that is consistent with VAP on membranes binding an FFAT motif of a large cytosolic protein ( Figure 4A and 4B). Thus, the 2:2 complex could form between full-length VAP and FFAT proteins with both VAP coiled-coil domains dimerized and both VAP molecules tethered to the same membrane by their C-terminal transmembrane domains ( Figure 4A ).
FFAT binding is a conserved VAP function
The FFAT motif binding site is highly conserved among VAP protein family members but is not conserved in the structurally similar MSP-1 ( Figure 3D ). This observation prompted us to assess whether the yeast VAP homologue Scs2p interacts with FFAT motifs using the same molecular mechanism as rat VAP-A and to assess the functional significance of FFAT interactions for Scs2p function. We used the structure of the VAP-FFAT complex to construct point mutations on the surface of rat VAP-A that we predicted would specifically prevent FFAT binding. We chose to mutate two residues on the VAP surface that interact with FFAT residue Phe476 ( Figure 3B ) to acidic residues by making the double point mutation K87D/M89D. As Mutating the homologous residues (K84D/L86D) in the yeast VAP homologue, Scs2p, disrupted Scs2p interactions with the FFAT motif of the yeast protein Opi1p in vitro ( Figure   1B ). The gel shift experiments confirm that Scs2p residues K84 and L86 are equivalent to rat VAP-A residues K87 and M89 and that both proteins probably bind to FFAT motifs by the same mechanism. We next tested if the K84D/L86D mutant of Scs2p was functional in yeast.
Strains lacking SCS2 are unable to activate INO1 and cannot grow in the absence of inositol.
Expression of wildtype Scs2p in an scs2∆ mutant strain allowed activation of INO1 and growth on medium lacking inositol. In contrast, Scs2p K84D/L86D failed to complement this growth phenotype ( Figure 5A ). Western blot analysis of total protein from yeast strains expressing wildtype or mutant Scs2p confirmed that the K84D/L86D mutant was expressed and stable in yeast ( Figure 5B ). Thus, the essential function of Scs2p in activating INO1 requires its evolutionarily conserved FFAT binding activity.
Overexpression of VAP or an FFAT binding mutant causes altered ER morphology
Several recent reports suggest that VAP-FFAT interactions may regulate ER morphology This regular pattern of dense patches was never observed with overexpression of wild-type VAP.
Since the K87D/M89D double point mutation does not affect VAP folding and structure it is likely that the observed pattern of dense patches results from the disruption of VAP-FFAT interactions.
Implications of the VAP-FFAT interaction
The VAP-FFAT co-crystal structure reveals the structural basis for VAP binding of FFAT motif containing proteins. We used the VAP-FFAT structure to design a stable VAP double point mutant that, although properly folded, is unable to bind FFAT motifs. We used this mutant to functionally characterize VAP-FFAT interactions and their conservation. We also characterized the effects of VAP protein overexpression on ER morphology in COS7 cells.
The VAP-FFAT structure should facilitate analysis of future questions concerning VAP interactions with FFAT motifs or with other proteins. For instance, we predict that a human isoform of VAP, VAP-C, is unable to bind FFAT motifs. Among other changes, VAP-C replaces Lys87 with His and Met89 with Ser. These changes are strikingly similar to the K87D/M89D mutant that we have shown does not bind FFAT motifs.
It is conceivable that FFAT proteins compete for VAP interactions. Thus, the primary sequence variability and the relative affinities of various FFAT motifs (Supplemental Figure 1A) that bind VAP proteins need to be analyzed. Our VAP-FFAT structure explains much of the primary sequence conservation observed in FFAT motifs. The primary VAP-FFAT interaction includes the first single ring aromatic residue in the EFFDAxE FFAT consensus sequence that binds in a hydrophobic cavity on VAP. The orientation of Phe476 in our structure suggests the possibility that FFAT motifs with Tyr at this position may still bind in a similar fashion. The secondary interactions in the 2:2 complex observed in VAP-FFAT crystals explain the high conservation of the Asp residue in the EFFDAxE FFAT consensus sequence. It is also noteworthy that the sidechain for the first Glu in the EFFDAxE FFAT consensus sequence is not ordered in our structure. This may suggest that this residue is not absolutely conserved in FFAT motifs. Similarly, there are a variety of potential hydrogen bonding partners for the final Glu in the EFFDAxE FFAT consensus sequence. This coincides with the observed sequence heterogeneity within previously identified FFAT motifs. We propose that a less stringent definition of this motif sequence is required and that a wider variety of cytosolic proteins may be targeted to VAP on ER membranes than has been anticipated.
Experimental Procedures
Expression and Purification: DNAs encoding Rattus norvegicus VAP-A and OSBP-L1a ∆41- Crystallographic Data Collection: Crystals were removed from sitting drops with a nylon loop and transferred to a cryoprotectant solution composed of equilibration buffer supplemented with 15% ethylene glycol. Crystals were then cryocooled directly in a 100 K cryostream and diffraction data were collected at beamline 8.2.1 of the Advanced Light Source using an ADSC Quantum-210 CCD detector. For the VAP (1-125) MAD experiment oscillation data were collected using inverse beam geometry in 15 ο wedges with all three wavelengths collected for each wedge simultaneously. For the VAP-FFAT complex moderate resolution SAD oscillation data were collected at the Selenium peak wavelength using inverse beam geometry in 5 ο wedges and a 1.9 Å resolution native data set was also collected. Diffraction data were processed using Mosflm/Scala (Collaborative.Computational.Project.Number. Four, 1994) . Data statistics are summarized in Tables 1 and 2 .
Structure Determination and Refinement: For VAP (1-125) the six expected selenium sites were found in anomalous difference Patterson maps calculated using the peak wavelength with an automated Patterson heavy atom search method (Grosse-Kunstleve and Brunger, 1999) . MAD phasing and density modification were carried out in CNS (Brunger et al., 1998) and resulted in a readily interpretable experimental electron density map. A partial model was built automatically with wARP (Perrakis et al., 1999) , and the remainder of the model was built using the program O (Jones et al., 1991 ). Model refinement was monitored using the free R value (Brunger, 1992) computed from a randomly omitted 10% of the observed diffraction data. Refinement was carried out in CNS using alternating rounds of simulated annealing, torsion angle molecular dynamics (Rice and Brunger, 1994) , restrained B factor refinement (Hendrickson, 1985) , and Electron density for the bound FFAT peptide was clear and refinement proceeded normally in space group P1. The 36 selenium sites from the 6 VAP molecules in the P1 cell were found by molecular replacement using the VAP (1-125) model in CNS. SAD phasing and density modification were carried out in CNS using a molecular envelope generated with the VAP (1-125) coordinates using MAMA (Kleywegt and Jones, 1999) . Density modified SAD phases were of reasonable quality. Native data extended to 1.9 Å and after minor rebuilding of the VAP
(1-125) model and addition of residues from the FFAT peptide, refinement was carried out in CNS with SAD experimental phases as outlined above. The bulk anisotropic B factor was somewhat high and addition of individual restrained B factors showed no improvement over group restrained B-factor refinement. Translation, libration, and screw-rotation (TLS) refinement (Winn et al., 2001 ) in REFMAC with 6 TLS groups, each consisting of a VAP (1-125) domain with bound peptide, improved both R free and R values by 3-4%. Tight NCS restraints were used for all atoms throughout refinement. The final model contains VAP residues 4-125 and OSBP-L1a residues 473-481. Two residues had uninterpretable electron density.
VAP residues 98-99 have their occupancies set to zero and ORP1 residues 473-475 were modeled as alanines. The final model has no residues in the disallowed region of the Ramachandran plot and R/R free values of 23% and 26%, respectively. Molecular graphics were generated with Pymol (DeLano, 2002) .
Gel Shift Assay: Native gel electrophoresis was carried out using 8-25% native Phast (Pharmacia) gels with native buffer strips (0.88 M L-alanine, 0.25 M Tris, pH 8.8, and 1 mM EDTA). Samples were mixed and incubated for at least 30 minutes in 50 mM Hepes, pH 7.5, 150 mM NaCl, 5 mM DTT before loading the gel.
Yeast Growth Assay: SCS2 was amplified from genomic DNA with upstream primer GTCAGAGCACTGAACGAGG and downstream primer CGCCTACTACACTAGGGAAACC.
The PCR product contained the SCS2 cDNA sequence (CDS), plus 506 bp upstream and 287 bp downstream of the SCS2 gene. The PCR product was first inserted into the pCR-Blunt II -TOPO vector (Invitrogen) and then subcloned as an EcoRI fragment into pRS313 (Sikorski and Hieter, 1989) and sequenced. Yeast growth assays were performed by making a suspension of ~2 x 10^7 cells per mL and a series of 10-fold dilutions were spotted onto SDC -inositolhistidine medium and incubated at 37 ο C for two days. The mobility of Scs2p (1-224) K84D/L86D is not affected by added peptide (lanes 7 and 8).
FFAT peptides alone were not visible on native gels. 
Tables
Values in parentheses are for the highest resolution bin. c Values are
, where ∆|F| is the dispersive (off-diagonal element), or Bijvoet difference (diagonal elements), computed between 500 and 1.7 Å resolution. d R = Σ(|F obs |-k|F calc |)/Σ|F obs |. e Free R value is the R value obtained for a test set of reflections, consisting of a randomly selected 10% subset of the diffraction data, not used during refinement. Figure 1A . Alignment of human proteins containing putative FFAT motifs selected from those found by a MEME/MAST search (http://meme.sdsc.edu/). A wide variety of proteins contain sequences that approximate the FFAT motif as initially defined (Loewen et al., 2003) and the motif still requires more precise definition. Those shown here are not predicted to reside in beta sheet secondary structure.
Supplemental Figure 1B 
